Does Influenza Vaccination Benefit Patients Hospitalized With Diabetes?
Does influenza vaccination protect patients hospitalized for diabetes against the risk for poor outcomes and complications?
Does influenza vaccination protect patients hospitalized for diabetes against the risk for poor outcomes and complications?
Researchers assessed the association between dexamethasone treatment and the occurrence of superinfections among patients with severe COVID-19.
Investigators assessed the risk for incident diabetes and hyperglycemia among patients with HIV infection receiving integrase strand transfer inhibitors.
Diabetes may increase the risk for long COVID symptoms fourfold, according to research presented at the annual meeting of the ADA.
Researchers assessed the effects of sofosbuvir/ledipasvir vs nitazoxanide when added to standard care for the treatment of mild to moderate COVID-19.
Researchers assessed outcomes and risk factors associated with thromboembolic events among patients with COVID-19 pneumonia.
Researchers assessed the prevalence of gestational diabetes among women with COVID-19 infection who were pregnant and the risk factors associated with severe disease.
While food insecurity is a leading public health issue, research shows that nutrition security may be a better target for disease prevention strategies.
Investigators assessed the impact of treatment with empagliflozin on patients with type 2 diabetes and chronic obstructive pulmonary disease.
Investigators conducted a cohort study to identify the risk of diabetes following the acute phase of COVID-19 infection.